Stocks / CRL

CRL stock forecast

CHARLES RIVER LABORATORIES INTERNATIONAL INC · Healthcare · Diagnostics & Research

The model's rating

Greatly Underperform

CRL is rated Greatly Underperform as of November 18, 2026: its medium-term return forecast is in the bottom fifth of the stocks the model scores.

Changed from Underperform on October 15, 2026.

Premium adds the numeric score behind this label, the medium-term return forecast, and today's full Upfront Picks.

Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.

CRL is not among the 20 largest holdings published for 2026 Q4. See the portfolio

CRL against the S&P 500

PeriodCRLS&P 500 (SPY)
1 month+11.1%-4.7%
3 months+14.9%-4.8%
Year to date+67.1%+7.9%
1 year+105.0%+11.8%

Total return, dividends included.

Key numbers

Price$333.25
Market cap15.97 Billion
P/E (trailing 12 months)311.4
P/S (trailing 12 months)4.0
P/B (latest quarter)4.8
Gross margin33.3%
Net profit margin1.0%
Return on equity1.3%
Beta1.3

As of November 4, 2026.

CRL and its closest peers

StockCompanyMarket capModel rating
RVTY REVVITY INC 17.02 Billion Underperform RVTY vs CRL
DGX QUEST DIAGNOSTICS INC 28.57 Billion Underperform DGX vs CRL
LH LABCORP HOLDINGS INC 30.11 Billion Underperform LH vs CRL
ILMN ILLUMINA INC 31.75 Billion Outperform
MTD METTLER TOLEDO INTERNATIONAL INC 34.55 Billion Greatly Underperform
IQV IQVIA HOLDINGS INC 42.49 Billion Underperform

Questions

What does the Upfront Investment model say about CRL?

The model rates CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL) "Greatly Underperform" as of November 18, 2026, which means its medium-term return forecast is in the bottom fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.

How is the CRL rating produced?

A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.

Is CRL in the Upfront Investment model portfolio?

CRL is not among the 20 largest holdings published for 2026 Q4.

The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.